The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancerNeus Martínez‐Bosch(Hospital Del Mar), Pilar Navarro(Consejo Superior de Investigaciones Científicas)OncotargetJune 21, 201610.18632/oncotarget.10199Cited by 11SaveCiteExport RISWatch citationsRelated PapersTissue Plasminogen Activator Induces Pancreatic Cancer Cell Proliferation by a Non-Catalytic Mechanism That Requires Extracellular Signal-Regulated Kinase 1/2 Activation through Epidermal Growth Factor Receptor and Annexin A2|American Journal Of Pathology|2007|76PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity|Science Advances|2026|0